Anti-tubercular activity

The condensation of 2-hydrazino-4-phenyl thiazole and 3-formyl-2-hydroxyquinoline has led to the synthesis of a new Schiff base (L) and its series of mononuclear Co(II), Ni(II) and Cu(II) complexes have also been synthesized. The synthesized Schiff base and its metal complexes were characterized by elemental analyses, spectral techniques (FT-IR, 1H-NMR, 13C-NMR, GC-MS, ESI-MS, UV-Vis, etc;) and magnetic studies. Elemental analyses reveals the [M(L)2.(H2O)2] stoichiometry, where M= Co(II), Ni(II) and Cu(II); “L”= doubly deprotonated ligand. The synthesized metal complexes are completely soluble in DMF and DMSO. The molar conductivity values indicate that, the metal complexes are non-electrolytic in nature. The newly synthesized compounds are good anti-tuberculosis and cytotoxic agents. They have been screened for in-vitro antibacterial and antifungal activities by MIC method. The DNA cleavage activity is studied by agarose gel electrophoresis method using pBR322 Plasmid DNA.

To synthesize and characterize novel thiazolidinone derivatives and screen them for anti tubercular activity. A series of ten 2-(substituted phenyl)-3-[{4-(1-naphthyl)-1, 3-thiazol-2-yl} amino]-5-methyl-1, 3-thiazolidin-4-ones (TM1-TM10) were synthesized from 1-acetyl naphthalene. The synthesized compound, characterized on the basis of satisfactory analytical and spectral (IR, H1NMR, Mass and elemental) data. Studies were carried out for the synthesized compounds which were also evaluated for anti-tubercular activity by using Lowenstein-Jensen (LJ) acid medium and screening by Cup plate method. Rifampicin (Lupin) is used as standard antitubercular agents. The synthesized compounds showed good anti tubercular activity, compared to standard drugs. Two of the compounds TM1 (Ar = 4-nitrophenyl) and TM6 (Ar = 3-fluorophenyl) exhibited significant anti-tubercular activity, as compared to standard drug Rifampicin. We report the successful synthesis of novel thiazolidinones, as well as their spectral characterization, and anti tubercular activity which, for some, is superior to currently used anti-tubercular agents.